Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication
Status:
Recruiting
Trial end date:
2022-04-13
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy of vonoprazan compared with esomeprazole as
first-line treatment for Helicobacter Pylori(Hp) eradication, as well as the safety and
economic benefits.
Phase:
Phase 4
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University